LONDON: Mediclinic International, a diversified private healthcare services group, announced that its Mediclinic Southern Africa division has received approval for its proposed acquisition of a controlling share in Matlosana Medical Health Services Proprietary Limited, based in Klerksdorp in the North-West Province of South Africa.

The acquisition includes two multi-disciplinary hospitals namely the 185-bed Wilmed Park Hospital and the 62-bed Sunningdale Hospital. In addition, the acquisition includes a 51% share in the 50-bed Parkmed Neuro Clinic psychiatric hospital.

Mediclinic Southern Africa initiated the acquisition process in 2015. Following various approval processes, the matter was referred to the Competition Appeal Court which has now ruled in favour of the acquisition, with an expected effective date around the middle of 2020.

Koert Pretorius, Chief Executive Officer of Mediclinic Southern Africa, said: “We are delighted to expand our current care offering within the North West Province of South Africa. Mediclinic remains focused on delivering high-quality healthcare services across the continuum of care and an excellent client experience. The Wilmed Park Hospital has consistently been recognised as one of the best hospitals within the North West Province and we are excited to work with the many doctors, nurses and staff at Matlosana to build on that reputation.

“The existing management team at the hospital will remain in place to ensure that the business continues to deliver the same high levels of care under the Mediclinic brand, as we expand our focus on delivering accessible, quality care at the best possible value for our patients.”

Marius van Tonder, CEO of Matlosana Health Services Proprietary Limited, said: “We look forward to a new era alongside Mediclinic where we have the opportunity to integrate the strengths of our two organisations towards providing expanded access to expertise for our patients.”

Edited by Kazim Rizvi